Cancer Stem Cells: A Patient's Perspective with Sandra Dillon

Published: Oct. 6, 2020, 9 p.m.

At 28, Sandra Dillon was diagnosed with myelofibrosis, a life-threatening blood disorder that can lead to acute leukemia. After participating in clinical trials and cutting edge treatments, Dillon has a deep appreciation for personalized medicine and genomics. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36357]